NYSE · Financial Services · Insurance—Life
MetLife, Inc. (MET)
As of Sep 25, 4:00 PM ET, MetLife (MET) last traded at $97.70, up 0.46% on the day. Its TickerHum research score is 67/100 (above average). It reported revenue of $79.4B for the twelve months ending 2026-06-30, up 8.7% year over year, with a 8.3% operating margin.
Ratings
- Valuation: 92/100 — Strongest input: price / sales (ttm) 0.8x. Weakest: price / earnings (ttm) 18.7x.
- Growth: 31/100 — Strongest input: revenue growth (ttm, yoy) +8.7 %. Weakest: diluted eps growth (ttm, yoy) -11.4 %.
- Profitability: 43/100 — Strongest input: return on equity 13.2 %. Weakest: net margin 4.6 %.
- Financial health: 72/100 — Strongest input: long-term debt / equity 0.69. Weakest: cash / long-term debt 1.02. Leverage ratios are less meaningful for banks and insurers.
- Momentum: 82/100 — Strongest input: 6-month return +40.1 %. Weakest: 1-year return +19.7 %.
- Attention: 62/100 — Strongest input: headlines in the last 7 days 50. Weakest: volume vs 3-month average 1.1x.
- Risk: 82/100 — Strongest input: annualised volatility (1y) 23.7 %. Weakest: max drawdown (1y) -18.3 %.
- Data confidence: 87/100 — Strongest input: latest financial period age (days) 59 d. Weakest: quote age (hours) 45 h.
Reported fundamentals
| Metric | Value | Period |
|---|---|---|
| Revenue | $79.4B | TTM ending 2026-06-30 · 10-Q |
| Revenue growth | 8.7% | TTM ending 2026-06-30 · 10-Q |
| Net income | $3.63B | TTM ending 2026-06-30 · 10-Q |
| Diluted EPS | $5.22 | TTM ending 2026-06-30 · 10-Q |
| Operating margin | 8.3% | TTM ending 2026-06-30 · 10-Q |
| Net margin | 4.6% | TTM ending 2026-06-30 · 10-Q |
| Cash | $19.3B | as of 2026-06-30 · 10-Q |
| Long-term debt | $18.88B | as of 2012-06-30 · 10-Q |
| Debt / equity | 0.69 | as of 2012-06-30 · 10-Q |
Source: SEC EDGAR XBRL company facts (CIK 0001099219).
Prices: Yahoo Finance (public) — Free public Yahoo Finance data. Prices may be delayed and are for information only.